BNCT
About
Products
News
Frontier
Contact
CN
Happy 2022 and everything goes well
News
2021.12.31
5170
分
享
Prev
Next
Share
Related News
Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality
2023.08.15
Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration
2023.12.13
Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff,presides as the honorary international chief IP consultant of Neuboron Medtech since 2021
2021.03.19
The 2nd International BNCT Development Forum Is Delayed
2020.05.27